The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid‐Induced Osteoporosis
Abstract
Objective: To develop recommendations for prevention and treatment of glucocorticoid‐induced osteoporosis (GIOP). Methods: We conducted a systematic review to synthesize the evidence for the benefits and harms of GIOP prevention and treatment options. The Grading of Recommendations Assessment, Development and Evaluation methodology was used to rate the quality of evidence. We used a group consensus process to determine the final recommendations and grade their strength. The guideline addresses initial assessment and reassessment in patients beginning or continuing long‐term (≥3 months) glucocorticoid (GC) treatment, as well as the relative benefits and harms of lifestyle modification and of calcium, vitamin D, bisphosphonate, raloxifene, teriparatide, and denosumab treatment in the general adult population receiving long‐term GC treatment, as well as in special populations of long‐term GC users. Results: Because of limited evidence regarding the benefits and harms of interventions in GC users, most recommendations in this guideline are conditional (uncertain balance between benefits and harms). Recommendations include treating only with calcium and vitamin D in adults at low fracture risk, treating with calcium and vitamin D plus an additional osteoporosis medication (oral bisphosphonate preferred) in adults at moderate‐to‐high fracture risk, continuing calcium plus vitamin D but switching from an oral bisphosphonate to another antifracture medication in adults in whom oral bisphosphonate treatment is not appropriate, and continuing oral bisphosphonate treatment or switching to another antifracture medication in adults who complete a planned oral bisphosphonate regimen but continue to receive GC treatment. Recommendations for special populations, including children, people with organ transplants, women of childbearing potential, and people receiving very high‐dose GC treatment, are also made. Conclusion: This guideline provides direction for clinicians and patients making treatment decisions. Clinicians and patients should use a shared decision‐making process that accounts for patients’ values, preferences, and comorbidities. These recommendations should not be used to limit or deny access to therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Self-citationRoss, A. C., Manson, J. E., Abrams, S. A., Aloia, J. F., Brannon, P. M., Clinton, S. K., Durazo-Arvizu, R. A., Gallagher, J. C., Gallo, R. L., Jones, G., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2704 · Cited by 4,026
MacLeod, A. M. (2009) · Kidney International · Cited by 2,218
Andrews, J., Guyatt, G., Oxman, A. D., Alderson, P., Dahm, P., Falck-Ytter, Y., Nasser, M., Meerpohl, J., Post, P. N., Kunz, R., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.03.013 · Cited by 1,416
Self-citationAndrews, J. C., Schünemann, H. J., Oxman, A. D., Pottie, K., Meerpohl, J. J., Coello, P. A., Rind, D., Montori, V. M., Brito, J. P., Norris, S., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.02.003 · Cited by 1,315
Self-citationUse of Inhaled Corticosteroids and Risk of Fractures
Van Staa, T. P., Leufkens, H. G. M., & Cooper, C. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.3.581 · Cited by 1,308
Use of oral corticosteroids and risk of fractures
Van Staa, T. P., Leufkens, H. G. M., Abenhaim, L., Zhang, B., & Cooper, C. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.6.993 · Cited by 1,263
Bolland, M. J., Grey, A., Avenell, A., Gamble, G. D., & Reid, I. R. (2011) · BMJ · doi:10.1136/bmj.d2040 · Cited by 851
Recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
American College of Rheumatology task force on Osteoporosis guidelines (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391104 · Cited by 848
We need minimally disruptive medicine
May, C., Montori, V. M., & Mair, F. S. (2009) · BMJ · doi:10.1136/bmj.b2803 · Cited by 734
Grossman, J. M., Gordon, R., Ranganath, V. K., Deal, C., Caplan, L., Chen, W., Curtis, J. R., Furst, D. E., McMahon, M., Patkar, N. M., et al. (2010) · Arthritis Care & Research · doi:10.1002/acr.20295 · Cited by 708
Self-citationCalcium/Vitamin D Supplementation and Cardiovascular Events
Hsia, J., Heiss, G., Ren, H., Allison, M., Dolan, N. C., Greenland, P., Heckbert, S. R., Johnson, K. C., Manson, J. E., Sidney, S., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.673491 · Cited by 662
Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update
American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200107)44:7<1496::aid-art271>3.0.co;2-5 · Cited by 647
Population‐based assessment of adverse events associated with long‐term glucocorticoid use
Curtis, J. R., Westfall, A. O., Allison, J., Bijlsma, J. W., Freeman, A., George, V., Kovac, S. H., Spettell, C. M., & Saag, K. G. (2006) · Arthritis Care & Research · doi:10.1002/art.21984 · Cited by 595
Saag, K. G., Koehnke, R., Caldwell, J. R., Brasington, R., Burmeister, L. F., Zimmerman, B., Kohler, J. A., & Furst, D. E. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90131-7 · Cited by 540
Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk
Gilbert-Barness, E. (1996) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.1996.02170300118039 · Cited by 459
Laan, R. F. J. M., van Riel, P. L. C. M., van de Putte, L. B. A., van Erning, L. J. T. O., van't Hof, M. A., & Lemmens, J. A. M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-10-199311150-00001 · Cited by 411
Angeli, A., Guglielmi, G., Dovio, A., Capelli, G., de Feo, D., Giannini, S., Giorgino, R., Moro, L., & Giustina, A. (2006) · Bone · doi:10.1016/j.bone.2006.02.005 · Cited by 365
Guidance for the adjustment of FRAX according to the dose of glucocorticoids
Kanis, J. A., Johansson, H., Oden, A., & McCloskey, E. V. (2011) · Osteoporosis International · doi:10.1007/s00198-010-1524-7 · Cited by 323
Fracture risk with intermittent high‐dose oral glucocorticoid therapy
De Vries, F., Bracke, M., Leufkens, H. G. M., Lammers, J. J., Cooper, C., & Van Staa, T. P. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22294 · Cited by 298
Bultink, I. E. M., Lems, W. F., Kostense, P. J., Dijkmans, B. A. C., & Voskuyl, A. E. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21110 · Cited by 253
Children and the Risk of Fractures Caused by Oral Corticosteroids
van Staa, T., Cooper, C., Leufkens, H., & Bishop, N. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.5.913 · Cited by 233
THE SCIENCE AND THERAPY OF GLUCOCORTICOID-INDUCED BONE LOSS
Lane, N. E., & Lukert, B. (1998) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70017-7 · Cited by 209
Self-citationGuideline panels should not GRADE good practice statements
Guyatt, G. H., Schünemann, H. J., Djulbegovic, B., & Akl, E. A. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.12.011 · Cited by 201
Self-citationApproval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases.
Ibrahim, A., Scher, N. S., Williams, G., Sridhara, R., Li, N., Chen, G., Leighton, J. C., Booth, B. P., Gobburu, J. V. S., Rahman, A., et al. (2003) · PubMed · Cited by 196
The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women
Hall, G. M., Spector, T. D., Jane Griffin, A., S. M. Jawad, A., Hall, M. L., & Doyle, D. V. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780361105 · Cited by 191
Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats
Patlas, N., Golomb, G., Yaffe, P., Pinto, T., Breuer, E., & Ornoy, A. (1999) · Teratology · doi:10.1002/(sici)1096-9926(199908)60:2<68::aid-tera10>3.0.co;2-h · Cited by 186
Pregnancy outcome following in utero exposure to bisphosphonates
Levy, S., Fayez, I., Taguchi, N., Han, J.-Y., Aiello, J., Matsui, D., Moretti, M., Koren, G., & Ito, S. (2009) · Bone · doi:10.1016/j.bone.2008.11.001 · Cited by 163
A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids
van Staa, T.-P., Geusens, P., Pols, H. A. P., de Laet, C., Leufkens, H. G. M., & Cooper, C. (2005) · QJM · doi:10.1093/qjmed/hci029 · Cited by 161
Rodd, C. J., Lang, B. A., Ramsay, T., Alos, N., Huber, A. M., Cabral, D. A., Scuccimarri, R., Miettunen, P., Roth, J., Atkinson, S. A., et al. (2011) · Arthritis Care & Research · doi:10.1002/acr.20589 · Cited by 145
Solomon, D. H., Katz, J. N., Jacobs, J. P., Tourette, A. M. L., & Coblyn, J. S. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10613 · Cited by 137
The use of bisphosphonates in women prior to or during pregnancy and lactation
Ioannis, S. P., Liakou, C. G., Katsalira, A., Trovas, G., Lyritis, G. P., Παπαϊωάννου, Ν., & Tournis, S. (2011) · HORMONES · doi:10.14310/horm.2002.1319 · Cited by 135
Practice patterns in patients at risk for glucocorticoid-induced osteoporosis
Feldstein, A. C., Elmer, P. J., Nichols, G. A., & Herson, M. (2005) · Osteoporosis International · doi:10.1007/s00198-005-2016-z · Cited by 121
LeBlanc, C. M. A., Ma, J., Taljaard, M., Roth, J., Scuccimarri, R., Miettunen, P., Lang, B. A., Huber, A. M., Houghton, K. M., Jaremko, J. L., et al. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2511 · Cited by 117
A systematic review and meta-analysis of glucocorticoid-induced osteoporosis in children
Hansen, K. E., Kleker, B., Safdar, N., & Bartels, C. M. (2014) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2014.02.002 · Cited by 88
Self-citationEffects of the Bisphosphonate, Alendronate, on Parturition in the Rat
Minsker, D. H., Manson, J. M., & Peter, C. P. (1993) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1993.1148 · Cited by 85
Effects of maternal bisphosphonate use on fetal and neonatal outcomes
Green, S. B., & Pappas, A. L. (2014) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp140041 · Cited by 82
Malignant hypercalcaemia in pregnancy and antenatal administration of intravenous pamidronate
Illidge, T., Hussey, M. J., & Godden, C. (1996) · Clinical Oncology · doi:10.1016/s0936-6555(05)80667-3 · Cited by 73
Li, E. K., Tam, L., Griffith, J. F., ZHU, T. Y., Li, T. K., Li, M., Wong, K. C., Chan, M. M., Lam, C. W. K., Chu, F. S. K., et al. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.081337 · Cited by 72
Boyce, R. W., Varela, A., Chouinard, L., Bussiere, J. L., Chellman, G. J., Ominsky, M. S., & Pyrah, I. T. G. (2014) · Bone · doi:10.1016/j.bone.2014.04.002 · Cited by 70
Monitoring of Patients on Long-Term Glucocorticoid Therapy: A Population-Based Cohort Study
Fardet, L., Petersen, I., & Nazareth, I. (2015) · Medicine · doi:10.1097/md.0000000000000647 · Cited by 67
High prevalence of vertebral deformity in premenopausal systemic lupus erythematosus patients
Borba, V. C., Matos, P. G., Viana, P. R. D. S., Fernandes, A. D. R. C., Sato, E. I., & Lazaretti‐Castro, M. (2005) · Lupus · doi:10.1191/0961203305lu2154oa · Cited by 66
Vitamin D Supplementation and Cardiovascular Disease Risk
Michos, E. D., & Blumenthal, R. S. (2007) · Circulation · doi:10.1161/circulationaha.106.686238 · Cited by 54
Reproduction toxicity studies with pamidronate.
Graepel, P., Bentley, P., Fritz, H., Miyamoto, M., & Slater, S. (1992) · PubMed · Cited by 52
Tatsuno, I., Sugiyama, T., Suzuki, S., Yoshida, T., Tanaka, T., Sueishi, M., & Saitō, Y. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1578 · Cited by 50
Reproductive toxicity of denosumab in cynomolgus monkeys
Bussiere, J. L., Pyrah, I. T. G., Boyce, R. W., Branstetter, D., Loomis, M., Andrews-Cleavenger, D., Farman, C. A., Elliott, G. S., & Chellman, G. J. (2013) · Reproductive Toxicology · doi:10.1016/j.reprotox.2013.07.018 · Cited by 43
Prevalence and risk factors of vertebral compression fractures in female SLE patients
Almehed, K., Hetenyi, S., Ohlsson, C., Carlsten, H., & Forsblad‐d’Elia, H. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3104 · Cited by 43
Kumagai, S., Kawano, S., Atsumi, T., Inokuma, S., Okada, Y., Kanai, Y., Kanai, Y., Kaburaki, J., Kameda, H., Suwa, A., et al. (2005) · PubMed · Cited by 38
A personal perspective on fracture risk assessment tools
Ettinger, B. B. (2008) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31817f3e4d · Cited by 21
Sugiyama, T., Suzuki, S., Yoshida, T., Suyama, K., Tanaka, T., Sueishi, M., & Tatsuno, I. (2010) · Gender Medicine · doi:10.1016/j.genm.2010.06.004 · Cited by 16
Sugiyama, T., Suzuki, S., Yoshida, T., Mayama, T., Hashimoto, N., Suyama, K., Tanaka, T., Sueishi, M., & Tatsuno, I. (2011) · Internal Medicine · doi:10.2169/internalmedicine.50.4443 · Cited by 15
Sugiyama, T., Tatsuno, I., Suzuki, S., Yoshida, T., Tanaka, T., Sueishi, M., & Saitō, Y. (2009) · Endocrine Journal · doi:10.1507/endocrj.k08e-318 · Cited by 11
Cited by
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Rovin, B. H., Adler, S. G., Barratt, J., Bridoux, F., Burdge, K. A., Chan, T. M., Cook, H. T., Fervenza, F. C., Gibson, K. L., Glassock, R. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.05.021 · Cited by 2,518
Lamb, C. A., Kennedy, N. A., Raine, T., Hendy, P. A., Smith, P. J., Limdi, J. K., Hayee, B., Lomer, M. C. E., Parkes, G. C., Selinger, C., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318484 · Cited by 2,346
The clinician's guide to prevention and treatment of osteoporosis
LeBoff, M. S., Greenspan, S. L., Insogna, K. L., Lewiecki, E. M., Saag, K. G., Singer, A. J., & Siris, E. S. (2022) · Osteoporosis International · doi:10.1007/s00198-021-05900-y · Cited by 1,487
Anders, H.-J., Saxena, R., Zhao, M.-H., Parodis, I., Salmon, J. E., & Mohan, C. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0141-9 · Cited by 958
Kiriakidou, M., & Ching, C. L. (2020) · Annals of Internal Medicine · doi:10.7326/aitc202006020 · Cited by 821
Metadata
- Authors
- Buckley, L., Guyatt, G., Fink, H. A., Cannon, M., Grossman, J., Hansen, K. E., Humphrey, M. B., Lane, N. E., Magrey, M., Miller, M., Morrison, L., Rao, M., Robinson, A. B., Saha, S., Wolver, S., Bannuru, R. R., Vaysbrot, E., Osani, M., Turgunbaev, M., Miller, A. S., & McAlindon, T.
- Venue
- Arthritis & Rheumatology
- Publisher
- Wiley
- Published
- 2017-06-06
- Volume
- 69
- Issue
- 8
- Pages
- 1521-1537
- ISSN
- 2326-5191 (ISSN-L)
- 2326-5205
- OpenAlex
- W2936396720
- Cited by
- 527
- References
- 52
- FWCI
- 48.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.